Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Gondi N. Kumar; Jennifer Dykstra; Ellen M. Roberts; Venkata K. Jayanti; Dean Hickman; John Uchic; Ye Yao; Bruce Surber; Samuel Thomas; G. Richard Granneman

Research ArticleArticle

Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Gondi N. Kumar, Jennifer Dykstra, Ellen M. Roberts, Venkata K. Jayanti, Dean Hickman, John Uchic, Ye Yao, Bruce Surber, Samuel Thomas and G. Richard Granneman

Drug Metabolism and Disposition August 1999, 27 (8) 902-908;

Gondi N. Kumar

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jennifer Dykstra

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ellen M. Roberts

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Venkata K. Jayanti

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dean Hickman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John Uchic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ye Yao

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bruce Surber

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Samuel Thomas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

G. Richard Granneman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Drug Metabolism and Disposition

Vol. 27, Issue 8

1 Aug 1999

Table of Contents
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Message Subject (Your Name) has forwarded a page to you from Drug Metabolism & Disposition

Message Body (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleArticle

Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Gondi N. Kumar, Jennifer Dykstra, Ellen M. Roberts, Venkata K. Jayanti, Dean Hickman, John Uchic, Ye Yao, Bruce Surber, Samuel Thomas and G. Richard Granneman

Drug Metabolism and Disposition August 1, 1999, 27 (8) 902-908;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleArticle

Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Gondi N. Kumar, Jennifer Dykstra, Ellen M. Roberts, Venkata K. Jayanti, Dean Hickman, John Uchic, Ye Yao, Bruce Surber, Samuel Thomas and G. Richard Granneman

Drug Metabolism and Disposition August 1, 1999, 27 (8) 902-908;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Plain text

Vertical Tabs

Jump to comment:

In this issue

Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals